U.S. ends J&J COVID-19 vaccine pause; shots to resume immediately

April 24th, 20210 WASHINGTON, D.C. — The U.S. can immediately resume use of Johnson & Johnson’s (J&J) COVID-19 vaccine, top health regulators said on Friday, ending a 10-day pause to investigate its link to extremely rare but potentially deadly blood clots. The Centers for Disease Control and Prevention (CDC) and Food and Drug...

CDC advisers delay decision on J&J vaccine pause

April 14th, 20210 Advisers to the Centers for Disease Control and Prevention (CDC) met Wednesday to review blood clot cases among people who received the Johnson & Johnson (J&J) COVID-19 vaccine. But the committee of experts declined to vote on whether use of the vaccine should resume, meaning the "pause" on the vaccine's use will remain at...